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Introduction
Liver cancer is one of the most common malignancies in the 
world.1 The major risk factors in liver cancer includes hepatitis 
viral infection, food additives, alcohol, aflatoxins, environmen-
tal and industrial toxic chemicals, air and water pollutants.2,3 
Diethylnitrosamine (DENA) is a well known hepatocarcinogenic 
agent present in tobacco smoke, water, cured and fried meals, 
cheddar cheese, agriculture chemicals and cosmetics and phar-
maceutical products.4-6 DENA is known to induce liver cancer 
in experimental animal models through inhibition of many 
enzymes involved in DNA repair mechanism.7 In rats, DENA is 
a potent hepatocarcinogen influencing the initiation stage of car-
cinogenesis during a period of enhanced cell proliferation accom-
panied by hepatocellular necrosis and induces DNA carcinogen 
adducts, DNA-strand breaks and in turn hepatocellular carcino-
mas without cirrhosis through the development of putative pre-
neoplastic focal lesions.8 Although there are many strategies for 
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the treatment of liver cancer,9-11 its therapeutic outcome remains 
very poor. Therefore, prevention seems to be the best strategy 
for lowering the incidence of this disease. In this regard, many 
compounds have been tested and proved efficacy against exper-
imentally-induced hepatocarcinogenesis including morin,12 sily-
marin,13 garlic,14 star anise,15 ganfujian granule,1 apigenin16 and 
the crude extracts of agarcus blazei.17
Thymoquinone (TQ), the main constituents of the volatile oil 
from Nigella sativa seeds is reported to protect laboratory animals 
against chemical toxicity and induction of carcinogenesis. In this 
regard, earlier studies have demonstrated that TQ has a consider-
able protective effect against reactive oxygen species (ROS) generat-
ing agents including carbon tetrachloride-induced hepatotoxicity,18 
doxorubicin-induced cardiotoxicity19 and gentamicin-induced 
nephropathy.20 Several studies reported that TQ supplementation 
in drinking water resulted in significant suppression of forestomach 
tumor induced by benzo(α) pyrene21 and 2-methyclonathrene.22 
Recently, Nagi et al.18 reported that oral administration of TQ is a www.landesbioscience.com  Oxidative Medicine and Cellular Longevity  255
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(Fig. 1B) and total bilirubin (Fig. 1C). DENA resulted in a sig-
nificant 858%, 71% and 364% increase in serum ALT, ALP 
and bilirubin, respectively, as compared to the control group. TQ 
supplementation alone for 7 days showed non-significant change. 
Interestingly, administration of TQ in combination with DENA 
resulted in a complete reversal of DENA-induced increase in serum 
ALT, ALP and bilirubin to the control values.
The effects of DENA, TQ and their combination on the oxi-
dative and nitrosative stress biomarkers, TBARS (Fig. 2A), NOx 
(Fig. 2B) and GSH (Fig. 2C), in liver tissues are shown in Figure 
2. DENA resulted in a significant 62 and 41% increase in TBARS 
and NOx, respectively and a significant 33% decrease in GSH as 
compared to the control group. Pretreatment with TQ resulted in a 
complete reversal of DENA-induced increase in TBARS and NOx 
and decrease in GSH in liver tissues to the control values.
Figure 3 shows the effects of DENA on the activity of the anti-
oxidant enzymes, GSHPx (Fig. 3C), CAT (Fig. 3C) and GST 
(Fig. 3C), in liver tissues from normal and TQ-supplemented rats. 
DENA resulted in a significant 43, 38 and 33% decrease in the 
activity of GSHPx, CAT and GST, respectively, as compared to the 
control group. In TQ supplemented rats, TQ resulted in a complete 
reversal of DENA-induced decrease in GSHPx, CAT and GST in 
liver tissues to the control values.
Figure 4 shows the effect of DENA on the mRNA expression 
of antioxidant enzymes, GSHPx (Fig. 4A), CAT (Fig. 4B) and 
GST (Fig. 4C), in liver tissues of normal and TQ-supplemented 
rats. DENA resulted in a significant 32, 40 and 52% decrease in 
GSHPx, CAT and GST, respectively, as compared to the control 
group. On the other hand, TQ supplementation resulted in a com-
plete reversal of DENA-induced decrease in mRNA expression of 
GSHPx, CAT and GST in liver tissues to the control values.
Figure 5 shows the histopathological changes in liver tissues 
induced by DENA in normal and TQ-supplemented rats. Liver 
from control rat showed normal liver histology with no signs of 
liver injury (total score: 2) manifested as normal hepatic nodules 
and central vein (Fig. 5A). Liver from rat treated with TQ alone 
showed no significant hepatic injury (total score: 3) manifested 
as areas with minimal vascular congestion and focal lympho-
plasmacytic infiltrates, most of which are seen around bile ducts   
(Fig. 5B). Liver from rat treated with DENA alone showed clear 
signs of severe hepatic injury (total score: 14) manifested as area 
with periportal and perivascular inflammatory infiltrates with dif-
fuse ballooning degeneration, intra-acinar lymphoplasmacytic and 
polymorphonuclear infiltrates with adjacent hepatocytes exhibiting 
feathery degeneration and regenerative cellular changes, prolifera-
tion of vascular channels are also noted in several areas, binucle-
ation, acidophilic bodies and nuclear enlargement are some of the 
regenerative cellular changes noted in most of the sections, granu-
loma formation accompanied by hepatocytes exhibiting ballooning 
degeneration and multinucleated giant cells are seen, within some 
of the granulomas (Fig. 5C). Liver from rat treated with TQ plus 
DENA showed mild hepatic injury (total score: 6) manifested as 
periportal inflammation with conspicuously dilated blood vessels 
and ballooning degeneration, mononuclear infiltrates associated 
with regenerative cellular changes of the adjacent hepatocytes, mild 
bile duct proliferation and intra-acinar inflammatory cell infiltrates.
promising prophylactic agent against chemical carcinogenesis and 
toxicity in liver tissues by increasing the activities of quinone reduc-
tase and glutathione transferase. Taken together, this prompted us 
to initiate this study to gain insights into the possibility of mech-
anism-based protection by TQ supplementation against DENA-
induced initiation of hepatocarcinogenesis.
Results
Figure 1 shows the effects of DENA, TQ and their combina-
tion on the indices of serum liver function, ALT (Fig. 1A), ALP   
Figure 1. effects of diethylnitrosamine (DeNA), thymoquinone (TQ) 
and their combination on the indices of serum liver function, alanine 
transaminase (ALT) (A), alkaline phosphatase (ALp) (B) and total bilirubin 
(C). Rats were randomly divided into 4 different groups of 10 animals 
each: Control, TQ, DeNA and TQ plus DeNA. Initiation of hepatocarcino-
genesis was induced by administration of a single dose of DeNA (200 
mg/kg, I.p.). TQ (4 mg/kg/day) was supplemented in drinking water for 
5 consecutive days before and 2 days after DeNA. Blood samples were 
drawn from the orbital venous plexus 48 hours after administration of 
DeNA and serum ALT, ALp and total bilirubin were measured. Data are 
presented as the mean ± seM. * and # indicate significant change from 
control and DeNA, respectively, at p < 0.05 using ANOVA followed by 
Tukey-Kramer as a post ANOVA test.256  Oxidative Medicine and Cellular Longevity  Volume 3 Issue 4
cytosol and plays an important role in detoxification and excre-
tion of xenobiotics.7 Induction of xenobiotic detoxifying enzymes 
is an additional mechanism by which antioxidant rich extracts 
may act as anticarcinogens as they compete with steps in xeno-
biotic activation and metabolize toxic compounds to non-toxic 
ones.41 As the activity of GST increased in TQ-treated rats, it 
appears that TQ induces greater coupling of electrophilic inter-
mediates with GSH. Increased generation of reactive oxygen spe-
cies and decreased antioxidant enzymes in liver tissues has been 
reported in many models of DENA-induced hepatocellular car-
cinoma.12-15 It has been reported that reactive oxygen species play 
Discussion
Chemoprevention is defined as the use of naturally occurring and/
or synthetic compounds in cancer therapy in which the occur-
rence of cancer can be entirely prevented, slowed or reversed.13 
Number of investigations are being conducted worldwide, to dis-
cover natural products that can suppress or prevent the process 
of carcinogenesis.23-26 Research on plants helped in the identifica-
tion of compounds with anticancer activity from non-tradition-
ally used plants that clinically used as useful drugs.27 The current 
study has been initiated to investigate whether TQ supplementa-
tion could inhibit the initiation stage of hepatic carcinogenesis 
induced by DENA in rats.
Data presented in the current study demonstrate that DENA 
increased serum indices of liver function including ALT, ALP 
and total bilirubin (Fig. 1) and caused severe histopathological 
lesions (total score: 14) in liver tissues (Fig. 5). It is well known 
that the elevation of ALT and ALP is credited to hepatocel-
lular damage and reflects the pathological alteration in biliary 
flow.12,28 In the current study, this observed increase in serum 
indices of liver function by DENA could be a secondary event 
following DENA-induced lipid peroxidation of hepatocyte mem-
branes with the consequent increase in the leakage of ALT, ALP 
and total bilirubin from liver tissues. An elevated level of serum 
indices of hepatocellular damage has been previously reported 
in many models of DENA-induced hepatocellular degenera-
tion.7,12,17,24,29 Fascinatingly, TQ supplementation prevented the 
increase in hepatic enzymes, suggesting that TQ may have poten-
tial protective effect against DENA-induced liver damage. This 
effect could be due to stabilization of hepatocyte membranes by 
TQ with the consequent decrease in the leakage of liver enzymes.
Catalase and GSHPx act as supporting antioxidant enzymes 
by converting hydrogen peroxide to water, thereby providing pro-
tection against reactive oxygen species.30 The reduction in activ-
ity of these enzymes may be caused by the increase in free radical 
production during DENA metabolism. Data from this study 
revealed that DENA significantly increased NOx and TBARS and 
decreased, GSHPx, CAT and GST activity and mRNA expres-
sion in liver tissues, suggesting that reactive oxygen and nitrogen 
species induced by DENA play an important role in DENA-
induced initiation of hepatic carcinogenesis. The contribution 
of oxidative stress during development of hepatocarcinogenesis 
and promotion of liver cancer has been recently confirmed.31-36 
Therefore, quenching lipid peroxidation and enhancing endoge-
nous enzymatic and non-enzymatic antioxidant status by chemo-
preventive compounds represent an effective strategy to prevent 
hepatocarcinogenesis.32-37 Increased oxidative stress biomarkers 
and depletion of enzymatic and non-enzymatic antioxidants have 
been reported in cancer patients and other human diseases.38,39 
Glutathione peroxidase is endogenous antioxidant selenoprotein 
present in the cytosol and mitochondrial matrix that participates 
in the defense mechanism. It is generally activated before the ini-
tiation of chronic oxidative stress and catalyzes the reduction of 
lipid and non-lipid hydroperoxides using two molecules of GSH 
and thereby curtails the quantity of biomolecules having destruc-
tive properties.40 Similarly, GST is a soluble protein located in 
Figure 2. effects of diethylnitrosamine (DeNA), thymoquinone (TQ) and 
their combination on the oxidative and nitrosative stress biomarkers, 
thiobarbituric acid reactive substances (TBARs) (A), nitrate/nitrite (NOx) 
(B) and reduced glutathione (Gsh) (C). Rats were randomly divided into 
4 different groups of 10 animals each: Control, TQ, DeNA and TQ plus 
DeNA. Initiation of hepatocarcinogenesis was induced by administra-
tion of a single dose of DeNA (200 mg/kg, I.p.). TQ (4 mg/kg/day) was 
supplemented in drinking water for 5 consecutive days before and 2 
days after DeNA Nitrate/nitrite (NOx) was measured in serum, whereas 
TBARs and Gsh were determined in liver tissue homogenates 48 hours 
after administration of DeNA. Data are presented as the mean ± seM. * 
and # indicate significant change from control and DeNA, respectively, 
at p < 0.05 using ANOVA followed by Tukey-Kramer as a post ANOVA 
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GSHPx, CAT and GST, in rat liver and induces quinone reduc-
tase in mice liver which may protect against chemical carcino-
genesis and toxicity.41,45
Methods
Animals. Adult male Wistar albino rats, weighing 180–200 g, 
were obtained from the Experimental Animal Care Center, 
College of Pharmacy, King Saud University (KSU), Riyadh, 
Kingdom of Saudi Arabia (KSA) and were housed in metabolic 
cages under controlled environmental conditions (25oC and a 12 h 
light/dark cycle). Animals had free access to pulverized stan-
dard rat pellet food and tap water unless otherwise indicated. 
The protocol of this study has been approved by Research Ethics 
Committee of College of Pharmacy, KSU, Riyadh, KSA.
Materials. Diethylnitrosamine (DENA) and Thymoquinone 
(TQ) were purchased from Sigma Chemical Co., (St. Louis, MO). 
DENA was dissolved in saline and injected in a single dose   
(200 mg/kg, I.P.) to initiate hepatic carcinogenesis. TQ was 
given in drinking water (50 mg/L) for 7 consecutive days. The 
calculated doses of TQ, based on the average daily water intake, 
were 4 mg/kg/day according to Badary et al.46 All other chemi-
cals used were of the highest analytical grade.
Experimental design. In the current study, the dose of DENA 
and the time required to study initiation stage of hepatic carci-
nogenesis in rats were adopted from Barbisan et al.17 To achieve 
the ultimate goal of this study, a total of 40 adult male Wistar 
albino rats were divided into four groups of 10 animals each. 
Rats of Group 1 (control group) received a single intraperitoneal 
(i.p.) injection of normal saline (2.5 ml/kg) for 7 consecutive 
days. Animals in Group 2 (TQ-supplemented) were given TQ   
(4 mg/kg/day) in drinking water for 7 consecutive days. Rats of 
Group 3 (DENA group) were injected with the same doses of 
normal saline for 5 consecutive days before and 2 days after a 
single dose of DENA (200 mg/kg, I.P.). Animals in Group 4 
(TQ supplemented-DENA group) were received the same doses 
of TQ for 5 consecutive days before and 2 days after a single dose 
of DENA (200 mg/kg, I.P.). Forty-eight hours after administra-
tion of DENA, animals were anesthetized with ether and blood 
samples were drawn from the orbital venous plexus. Serum was 
separated by centrifugation for 5 min at 1,500 g and stored at 
-20°C until analysis. This was used for the determination of ALT, 
ALP activities, total bilirubin and total nitrate/nitrite (NOx). All 
animals were then sacrificed by decapitation and their livers were 
rapidly excised, weighed, washed with saline, blotted with a piece 
of filter paper and homogenized in normal saline to yield a 10% 
(w/v) tissue homogenate, using a Branson sonifier (250 VWR 
Scientific, Danbury, CT). Liver specimens from each group were 
removed to be examined histopathologically, they were fixed in 
10% neutral buffered formalin, sectioned at 3 µm and stained 
with Hematoxylin and Eosin (H & E) stain for light microscopic 
examination.
Histopathological examination of liver tissues. To avoid 
any type of bias, the slides were coded and examined by a 
histopathologist who was blinded to the treatment groups. 
Grading of injury was according to the following parameters: 
a major role in tumor promotion through interaction with the 
critical macromolecules including lipids, DNA and DNA repair 
systems.42 Moreover, NOx is known to inhibit DNA repair pro-
teins, thereby inhibiting the ability of the cell to repair damaged 
DNA.43,44 Treatment of rats with TQ resulted in upregulation 
of the GSHPx, CAT and GST genes with the consequent eleva-
tion of hepatic GSHPx, CAT and GST levels to overcome oxida-
tive stress induced during DENA metabolism. Our results are 
consistent with recent studies which have demonstrated that TQ 
supplementation increases the expression of antioxidant genes, 
Figure 3. effects of diethylnitrosamine (DeNA) on the activity of the 
antioxidant enzymes, glutathione peroxidase (Gshpx) (A), catalase 
(CAT) (B) and glutathione transferase (GsT) (C), in liver tissues from nor-
mal and thymoquinone (TQ)-supplemented rats. Rats were randomly 
divided into 4 different groups of 10 animals each: Control, TQ, DeNA 
and TQ plus DeNA. Initiation of hepatocarcinogenesis was induced by 
administration of a single dose of DeNA (200 mg/kg, I.p.). TQ (4 mg/kg/
day) was supplemented in drinking water for 5 consecutive days before 
and 2 days after DeNA. Gshpx, CAT and GsT activities were determined 
in liver tissue homogenates 48 hours after administration of DeNA. Data 
are presented as the mean ± seM. * and # indicate significant change 
from control and DeNA, respectively, at p < 0.05 using ANOVA followed 
by Tukey-Kramer as a post ANOVA test.258  Oxidative Medicine and Cellular Longevity  Volume 3 Issue 4
Determination of glutathione peroxidase, catalase and glu-
tathione transferase activity and mRNA expression in liver 
tissues. The activity of glutathione peroxidase (GSHPx) was 
determined according to the method of Lawrence and Burk,50 
The changes in the absorbance at 340 nm were recorded at 1 
min interval for 5 min and the results were expressed as µmol/
min/g tissue. The catalase (CAT) activity was determined spec-
trophotometrically by the method of Higgins et al.51 which is the 
assay of hydrogen peroxide. The activity was expressed as µmol/
min/g tissue using the molar absorbance of 43.6 for hydrogen 
peroxide. Glutathione transeferase activity was assayed as previ-
ously described by Habig et al.52 using 1-chloro-2, 4-dinitroben-
zene and the results were expressed as nmol/min/mg protein.
Total RNA extraction. The expression of glutathione per-
oxidase, catalase and glutathione transferase was determined by 
real rime PCR Applied biosystem. Total RNA were extracted 
from liver tissue by Trizol method according to the standard 
protocol as previously described by Chomczynski.53 In Brief, 
RNA was extracted by homogenization (Polytron; Kinematica, 
Lucerne, Switzerland) in TRIzol reagent (Invitrogen, CA) at 
(1) Degeneration and intracellular accumulation (% of liver 
parenchyma involvement with ballooning degeneration, feath-
ery degeneration, swelling of hepatocytes and steatosis):   
None = 0, <25% of the liver parenchyma involved = +1, 25–50% 
of the liver parenchyma involved = +2, 50–75% of the liver 
parenchyma involved = +3 and >75% of the liver parenchyma 
involved = +4; (2) Necrosis and apoptosis (ischemic coagulation 
necrosis, centrilobular necrosis and apoptotic cell death: None 
= 0, <25% of the liver parenchyma involved = +1, 25–50% 
of the liver parenchyma involved = +2, 50–75% of the liver 
parenchyma involved = +3 and >75% of the liver parenchyma 
involved = +4 (3) Inflammation (injury to the liver associated 
with an influx of acute or chronic inflammatory cells (usually 
periportal): None = 0, one focus of periportal inflammation per 
section = +1, 2–4 foci of periportal inflammation per section = 
+2, 5 or more foci of periportal inflammation with concomi-
tant interstitial inflammation = +3; (4) Regeneration (mitosis 
and thickening of hepatocyte cords): None = 0, <25% of the 
liver parenchyma involved = +1, 25–50% of the liver paren-
chyma involved = +2, 50–75% of the liver parenchyma involved 
= +3, >75% of the liver parenchyma involved = +4; (5) Fibrosis 
(proliferation of dense fibrous connective tissue, usually seen 
surrounding liver lobules, associated with disruption of normal 
liver architecture): None = 0, <25% of the liver parenchyma 
involved = +1, 25–50% of the liver parenchyma involved = +2, 
50–75% of the liver parenchyma involved = +3, >75% of the 
liver parenchyma involved = +4. The scoring system used was 
according to the following scale: (A) No hepatotoxicity: 0–3, 
(B) Mild hepatotoxicity: 4–8, (C) Moderate hepatotoxicity: 
9–13, (D) Severe hepatotoxicity: 14–19.
Measurements of liver function. The activities of ALT and 
ALP as well as total bilirubin in serum were determined using 
Randox commercially available kits (Randox Laboratories Ltd., 
Diamond Road, Crumlin, Co., Antrim, UK).
Determination of reduced glutathione and lipid peroxida-
tion in liver tissues. The tissue levels of the acid soluble thiols, 
mainly GSH, were assayed spectrophotometrically at 412 nm, 
according to the method of Ellman,47 using a Shimadzu (Tokyo, 
Japan) spectrophotometer. The contents of GSH were expressed 
as mmol/g wet tissue. The degree of lipid peroxidation in liver 
tissues was determined by measuring thiobarbituric acid reactive 
substances (TBARS) in the supernatant tissue from homogenate 
Ohkawa et al.48 The homogenates were centrifuged at 1,500 g and 
supernatant was collected and used for the estimation of TBARS. 
The absorbance was measured spectrophotometrically at 532 nm 
and the concentrations were expressed as nmol TBARS/g wet 
tissue.
Determination of total nitrate/nitrite concentrations in 
serum. Total nitrate/nitrite (NOx), an index of nitric oxide 
(NO) production, was measured as stable end product, nitrite, 
according to the method of Miranda et al.49 The assay is based on 
the reduction of nitrate by vanadium trichloride combined with 
detection by the acidic griess reaction. The diazotization of sulfa-
nilic acid with nitrite at acidic pH and subsequent coupling with 
N-(10 naphthyl)-ethylenediamine produced an intensely colored 
product that is measured spectrophotometrically at 540 nm.
Figure 4. effects of diethylnitrosamine (DeNA) on the mRNA expression 
of antioxidant enzymes, glutathione peroxidase (Gshpx) (A), catalase 
(CAT) (B) and glutathione transferase (GsT) (C), in liver tissues of normal 
and TQ-supplemented rats. Rats were randomly divided into 4 different 
groups of 10 animals each: Control, TQ, DeNA and TQ plus DeNA. Initia-
tion of hepatocarcinogenesis was induced by administration of a single 
dose of DeNA (200 mg/kg, I.p.). TQ (4 mg/kg/day) was supplemented 
in drinking water for 5 consecutive days before and 2 days after DeNA. 
Gshpx, CAT and GsT mRNA expression were determined in liver tissues 
48 hours after administration of DeNA. Data are presented as the mean 
± seM. * and # indicate significant change from control and DeNA, 
respectively, at p < 0.05 using ANOVA followed by Tukey-Kramer as a 
post ANOVA test.www.landesbioscience.com  Oxidative Medicine and Cellular Longevity  259
reverse transcription with a SuperScript™ first-strand synthesis 
system kit (Invitrogen, CA), according to the manufacturer’s 
instructions.
EVAgreen polymerase chain reaction. The genes levels were 
measured using qPCR GreenMaster with UNG/ROX (Jena 
Bioscience, Germany) with EvaGreen dye and the 2-∆∆Ct method. 
We used GAPDH gene as the housekeeping gene. Briefly, a 
standard 25 µl reaction mixture contained in final concentra-
tion of 1x AMV/TF1 reaction buffer, 0.2 mM dNTPs mix,   
3 mM MgSO4, 0.1 U AMV reverse transcriptase, 0.1 U Tf1 DNA 
polymerase, 0.8 U RNase inhibitor (Jena Bioscience Germany), 
0.5 µM of each reverse and forward primers GPX R. AGA GCG 
GGT GAG CCT TCT and F. GGG CAA AGA AGA TTC 
maximum speed for 90–120 s. The homogenate was incubated 
for 5 min at room temperature. A 1:5 volume of chloroform was 
added, and the tube was vortexes and subjected to centrifuga-
tion at 12,000 g for 15 min. The aqueous phase was isolated, 
and one-half of the volume of isopropanol was added to precipi-
tate the RNA. After centrifugation and washing the total RNA 
was finally eluted in DEPC-treated H2O, and the quantity and 
integrity were characterized using a UV spectrophotometer 
(UVmini1240 SHIMADZU). RNA was electrophoresed on ethid-
ium bromide stained agarose gel. The isolated RNA has an A 
260/280 ratio of 1.9–2.1.
First-strand cDNA synthesis using superScript II RT. 
First-strand cDNA was synthesized from 1 µg of total RNA by 
Figure 5. effects of diethylnitrosamine (DeNA), thymoquinone (TQ) and their combination on histopathological changes in liver tissues. Rats were 
randomly divided into four different groups of 10 animals each: Control, TQ, DeNA and TQ plus DeNA. Initiation of hepatocarcinogenesis was induced 
by administration of a single dose of DeNA (200 mg/kg, I.p.). TQ (4 mg/kg/day) was supplemented in drinking water for 5 consecutive days before and 2 
days after DeNA. Liver specimens from each group were removed to be examined histopathologically, they were fixed in 10% neutral buffered forma-
lin, sectioned at 3 µm and stained with hematoxylin and eosin (h & e) stain for light microscopic examination. (A) Liver from control rat showing nor-
mal liver histology with normal hepatic nodules and central vein (X10). (B) Liver from rat treated with thymoquinone (TQ) showing areas with minimal 
vascular congestion and focal lymphoplasmacytic infiltrates, most of which are seen around bile ducts. (arrows, 10X). (C) Liver from rat treated with 
diethylnitrosamine (DeNA) showing area with periportal and perivascular inflammatory infiltrates, with diffuse ballooning degeneration. (C1, X10), 
intra-acinar lymphoplasmacytic and polymorphonuclear infiltrates, with adjacent hepatocytes exhibiting feathery degeneration and regenerative 
cellular changes (C2, X40), proliferation of vascular channels (circle) are also noted in several areas (C3, X10), binucleation (short thin arrow), acidophilic 
bodies (long thin arrow) and nuclear enlargement (thick arrow) are some of the regenerative cellular changes noted in most of the sections (C4, X40), 
granuloma formation (arrow) accompanied by hepatocytes exhibiting ballooning degeneration (C5, X20) and multinucleated giant cells (arrow) are 
seen, within some of the granulomas (C6, X40). (D) Liver from rat treated with thymoquinone (TQ) plus diethylnitrosamine (DeNA) showing periportal 
inflammation with conspicuously dilated blood vessels and ballooning degeneration ((D1, X10), mononuclear infiltrates associated with regenerative 
cellular changes of the adjacent hepatocytes (D2, X40), mild bile duct proliferation (D3, 40X) and intra-acinar inflammatory cell infiltrates (D4, 10X).260  Oxidative Medicine and Cellular Longevity  Volume 3 Issue 4
Glutathione S transferase and Glutathione peroxidase amplifica-
tion indicates the existence of a single band for each gene.
Statistical analysis. Differences between obtained values 
(mean ± SEM, n = 10) were carried out by one way analysis 
of variance (ANOVA) followed by the Tukey-Kramer multiple 
comparison test. A p value of 0.05 or less was taken as a criterion 
for a statistically sig.
Conclusions
Data from this study suggest that: (1) decreased mRNA expres-
sion of GSHPx, CAT and GST during DENA-induced initia-
tion of hepatic carcinogenesis, (2) TQ supplementation prevents 
the development of DENA-induced initiation of liver cancer by a 
mechanism related, at least in part, to the ability of TQ to decrease 
oxidative stress and preserve the activity and expression of antioxi-
dant enzymes. This will open new perspectives for the use of TQ 
alone or in combination with other natural chemopreventive com-
pounds to prevent, slow or reverse the occurrence of liver cancer.
Acknowledgements
The present work was supported by operating grant from 
Research Center, College of Pharmacy, King Saud University 
(CPRC 232).
CAG GTT, GHST R. GTC AGC CTG TTC CCT ACA AG 
and F. GCC TTC TAC CCG AAG ACA CCT T and CAT R. 
GTA CGA CTC ACT ATA GGG ACA CGA GGT CCC AGT 
TAC CAT and F. AGG TGA CAC TAT AGA ATA GTG GTT 
TTC ACC GAC GAG AT (Jena Bioscience, Germany), 100 ng 
of cDNA and RNase free water. Target genes were amplified in 
low-profile 0.2 ml tube stripes (Axygen, CA). The amplification 
was performed in Applied biosystem (Applied biosystem, USA). 
No template control (NTC) was used as a negative control. The 
cycling programme consists of pre-denaturation at 95°C for 
10 min followed by 40 cycles of denaturation at 94°C for 30 s, 
annealing/extension temperature at 60°C for 1 min. Finally, a 
melting curve analysis was undertaken from 60 to 95°C. The 
real time PCR yields a value (Ct) having the threshold cycle of 
specific target gene amplification at which the PCR products are 
first detected via flouorescence.
Melting curve and agarose gel electrophoresis analysis. 
Following amplification, melting curve analysis was performed 
to verify the correct product according to its specific melt-
ing temperature (Tm). The melting curve analysis software of 
applied biosystem analyzed the results. Amplification plots and 
Tm values were routinely analyzed to confirm the specificities 
of the amplicons for EvaGreen PCR amplification. Agarose gel 
electrophoresis for analyzing the product of GAPDH, Catalase, 
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